Chest CT utilization in COVID-19: a dosimetric and diagnostic-quality study.

The purpose of this study is to look at the variations in chest computed tomography (CT) use, radiation dose and image quality in the 2019 novel coronavirus (COVID-19) pneumonia patients in Saudi Arabia. This is a retrospective study of 402 patients with COVID-19, who were treated between February and October 2021. Radiation dose was estimated using metrics of volume CT dose index (CTDIvol) and size-specific dose estimate (SSDE). The imaging performance of the CT scanners was evaluated by measuring different parameters, such as resolution and CT number uniformity, with an ACR-CT accreditation phantom. Expert radiologists assessed the diagnostic quality and occurrence of artefacts. For all of the image quality parameters tested, the majority of the scanner sites (80%) were found to be within the suggested acceptance limits. Ground-glass opacities were the most common finding in our patient sample (54%). On chest CT exams with typical appearance of COVID-19 pneumonia, the most respiratory motion artefacts (56.3%) were present, followed by those with indeterminate appearance (32.2%). There were significant differences in CT utilization, CTDIvol and SSDE across the collaborated sites. The use of CT scans and radiation doses varied in the COVID-19 patients, highlighting the optimizations of CT protocols at participating sites.